SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Meghmani Organics gains with arm planning to set up hydrogen peroxide project

19 Apr 2017 Evaluate

Meghmani Organics is currently trading at Rs. 40.15, up by 0.40 points or 1.01% from its previous closing of Rs. 39.75 on the BSE.

The scrip opened at Rs. 40.10 and has touched a high and low of Rs. 40.70 and Rs. 39.80 respectively. So far 2,06,000 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 52.40 on 10-Oct-2016 and a 52 week low of Rs. 26.20 on 20-Apr-2016.

Last one week high and low of the scrip stood at Rs. 41.30 and Rs. 37.85 respectively. The current market cap of the company is Rs. 1,019.80 crore.

The promoters holding in the company stood at 55.06%, while Institutions and Non-Institutions held 3.47% and 41.47% respectively.

Meghmani Organics’ subsidiary - Meghmani Finechem (MFL) is planning to set up hydrogen peroxide project and expansion of caustic chlorine & captive power plant capacity. The plant will be set up at existing manufacturing facility of MFL situated at GIDC Dahej in Bharuch and will be commissioned on June 30, 2019. The cost of the project is estimated at Rs 400 crore and it will be funded from internal accruals.


Meghmani Organics is a leading manufacturer of pigment and pesticide products in the country and is the recipient of several prestigious awards in recognition of its outstanding business performance.


Meghmani Org-Amal Share Price

64.05 0.00 (0.00%)
17-May-2021 18:01 View Price Chart
Peers
Company Name CMP
UPL 665.00
PI Industries 3144.45
Bayer CropScience 4900.45
Sharda Cropchem 1109.70
Sumitomo Chemical 441.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×